Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Drug Utilization Review

"Drug Utilization Review" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

Formal programs for assessing drug prescription against some standard. Drug utilization review may consider clinical appropriateness, cost effectiveness, and, in some cases, outcomes. Review is usually retrospective, but some analysis may be done before drugs are dispensed (as in computer systems which advise physicians when prescriptions are entered). Drug utilization review is mandated for Medicaid programs beginning in 1993.


This graph shows the total number of publications written about "Drug Utilization Review" by people in Harvard Catalyst Profiles by year, and whether "Drug Utilization Review" was a major or minor topic of these publication.
Bar chart showing 138 publications over 25 distinct years, with a maximum of 21 publications in 2007
To see the data from this visualization as text, click here.
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.